Tomoya Okada

411 total citations
13 papers, 323 citations indexed

About

Tomoya Okada is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Tomoya Okada has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Tomoya Okada's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Tomoya Okada is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Tomoya Okada collaborates with scholars based in Japan, Germany and Ireland. Tomoya Okada's co-authors include Tsunehiko Nishimura, Shoichi Shimada, Masaya Tohyama, Yoshiyuki Watanabe, Masahiro Fujita, Kohji Sato, Patrick D. Schloss, Hideo Kusuoka, Mitsuhiro Nishimura and Yasushi Ito and has published in prestigious journals such as FEBS Letters, Anesthesiology and Tetrahedron Letters.

In The Last Decade

Tomoya Okada

12 papers receiving 316 citations

Peers

Tomoya Okada
Hannah Furby United Kingdom
Andreas E. Theodorou United Kingdom
HS Mayberg United States
F Zerbi Italy
Jaskaran Singh United States
Ian Phillips United States
Tomoya Okada
Citations per year, relative to Tomoya Okada Tomoya Okada (= 1×) peers Tsuyoshi Hirose

Countries citing papers authored by Tomoya Okada

Since Specialization
Citations

This map shows the geographic impact of Tomoya Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Okada more than expected).

Fields of papers citing papers by Tomoya Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Okada. The network helps show where Tomoya Okada may publish in the future.

Co-authorship network of co-authors of Tomoya Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Okada. A scholar is included among the top collaborators of Tomoya Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Okada. Tomoya Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Nomoto, Akihiro, Tomoya Okada, Yuki Yamamoto, et al.. (2021). Oxidative Synthesis of Acid Blue 7 Dye Catalyzed by CuO/Silicotungstic Acid in Water-Phase. Materials. 14(16). 4505–4505. 2 indexed citations
3.
Okada, Tomoya. (2004). . Nihon Toseki Igakkai Zasshi. 37(8). 1567–1568.
4.
Ito, Yasushi, Masahiro Fujita, Shoichi Shimada, et al.. (1999). Comparison between the decrease of dopamine transporter and that ofL-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models. Synapse. 31(3). 178–185. 33 indexed citations
5.
Ito, Yasushi, Masahiro Fujita, Shoichi Shimada, et al.. (1999). Comparison between the decrease of dopamine transporter and that of L‐DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models. Synapse. 31(3). 178–185. 1 indexed citations
6.
Nishimura, Mitsuhiro, Kohji Sato, Tomoya Okada, et al.. (1998). MK‐801 blocks monoamine transporters expressed in HEK cells. FEBS Letters. 423(3). 376–380. 12 indexed citations
7.
Okada, Tomoya, Shoichi Shimada, Kohji Sato, et al.. (1998). Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells. Neuroscience Research. 30(1). 87–90. 29 indexed citations
8.
Nishimura, Mitsuhiro, Kohji Sato, Tomoya Okada, et al.. (1998). Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells . Anesthesiology. 88(3). 768–774. 98 indexed citations
9.
Okada, Tomoya, Masahiro Fujita, Shoichi Shimada, et al.. (1998). Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines. Nuclear Medicine and Biology. 25(1). 53–58. 25 indexed citations
10.
Goto, Hideki, Katsuhiro Kobayashi, Yoshihiro Sawada, et al.. (1997). Detection of impaired fatty acid metabolism in right ventricular hypertrophy: Assessment by I-123 β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography. Annals of Nuclear Medicine. 11(3). 207–212. 24 indexed citations
11.
Watanabe, Yoshiyuki, Masahiro Fujita, Yasushi Ito, et al.. (1997). Brain dopamine transporter in spontaneously hypertensive rats.. PubMed. 38(3). 470–4. 87 indexed citations
12.
Tanaka, Kiyoshi, Teiji Kimura, Tomoya Okada, Xing Chen, & Fumio Yoneda. (1987). Synthesis of chiral 5-deazaflavin derivatives and their use in asymmetric reduction of ethyl benzoylformate.. Chemical and Pharmaceutical Bulletin. 35(4). 1397–1404. 1 indexed citations
13.
Tanaka, Kiyoshi, et al.. (1984). Preparation of chiral 5-deazaflavin derivatives and their asymmetric reduction of ethyl benzoylformate. Tetrahedron Letters. 25(16). 1741–1742. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026